Posted by Michael Wonder on 10 May 2017
Hepatitis C drug could avert liver transplants - doctors
10 May 2017 - Hepatitis C sufferers say a highly-expensive drug PHARMAC is considering offering to more patients has "given them life".
Harvoni, which costs about $1000 per pill, was funded by Pharmac last July for patients who were sick enough to be considered for a liver transplant.
On Sunday, as part of a pre-Budget announcement, PHARMAC said it intended to make Harvoni - a tablet that is taken orally - available to patients whose illness was not as advanced.
